These incidents, though unrelated, point to a problem for psychedelic research: Many of the studies underpinning these ...

The expanded approval intensifies the rivalry with Jazz Pharmaceuticals, which has previously attempted to block Lumryz’s ...

It’s important to spot early signs of sleep disorders to stay healthy. If you ignore these signs, they can turn into bigger ...

Avadel Pharmaceuticals plc AVDL announced that the FDA has approved its supplemental new drug application (sNDA) seeking ...

Lumryz is an extended-release formulation of sodium oxybate, a central nervous system (CNS) depressant. Its therapeutic effects are believed to be mediated through GABA B actions at noradrenergic and ...

Non-vitamin K oral anticoagulants (NOACs) are a class of drugs that can treat and prevent blood clots. Learn more the ...

Avadel Pharmaceuticals has won expanded Food and Drug Administration approval of its narcolepsy drug Lumryz for use in children. Avadel on Thursday said the FDA nod covers Lumryz for the treatment of ...

But in some cases, it can become severe and cause complications like bacterial infections, infection of the brain, pneumonia, ...